Cormorant Global Healthcare Master Fund LP 13D and 13G filings for Rain Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:01 pm Purchase | 2022-12-31 | 13G | Rain Therapeutics Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 2,733,977 9.990% | 796,176 (+41.09%) | Filing |
| 2022-02-14 3:16 pm Purchase | 2021-12-31 | 13G | Rain Therapeutics Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 1,937,801 9.990% | 105,148 (+5.74%) | Filing |
| 2021-05-07 4:01 pm Purchase | 2021-04-27 | 13G | Rain Therapeutics Inc. RAIN | Cormorant Global Healthcare Master Fund LP | 1,832,653 9.990% | 1,832,653 (New Position) | Filing |